Oriented clonal cell dynamics enables accurate growth and shaping of vertebrate cartilage

  1. Marketa Kaucka
  2. Tomas Zikmund
  3. Marketa Tesarova
  4. Daniel Gyllborg
  5. Andreas Hellander
  6. Josef Jaros
  7. Jozef Kaiser
  8. Julian Petersen
  9. Bara Szarowska
  10. Phillip T Newton
  11. Vyacheslav Dyachuk
  12. Lei Li
  13. Hong Qian
  14. Anne-Sofie Johansson
  15. Yuji Mishina
  16. Josh Currie
  17. Elly M Tanaka
  18. Alek Erickson
  19. Andrew Dudley
  20. Hjalmar Brismar
  21. Paul Southam
  22. Enrico Coen
  23. Min Chen
  24. Lee S Weinstein
  25. Ales Hampl
  26. Ernest Arenas
  27. Andrei S Chagin
  28. Kaj Fried  Is a corresponding author
  29. Igor Adameyko  Is a corresponding author
  1. Karolinska Institutet, Sweden
  2. Brno University of Technology, Czech Republic
  3. Uppsala University, Sweden
  4. Masaryk University, Czech Republic
  5. Medical University Vienna, Austria
  6. University of Michigan School of dentistry, United States
  7. Technische Universität Dresden, Germany
  8. University of Nebraska Medical Center, United States
  9. Royal Institute of Technology, Sweden
  10. John Innes Centre, United Kingdom
  11. National Institutes of Health, United States

Abstract

Cartilaginous structures are at the core of embryo growth and shaping before the bone forms. Here we report a novel principle of vertebrate cartilage growth that is based on introducing transversally-oriented clones into pre-existing cartilage. This mechanism of growth uncouples the lateral expansion of curved cartilaginous sheets from the control of cartilage thickness, a process which might be the evolutionary mechanism underlying adaptations of facial shape. In rod-shaped cartilage structures (Meckel, ribs and skeletal elements in developing limbs), the transverse integration of clonal columns determines the well-defined diameter and resulting rod-like morphology. We were able to alter cartilage shape by experimentally manipulating clonal geometries. Using in silico modeling, we discovered that anisotropic proliferation might explain cartilage bending and groove formation at the macro-scale.

Article and author information

Author details

  1. Marketa Kaucka

    Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  2. Tomas Zikmund

    Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  3. Marketa Tesarova

    Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  4. Daniel Gyllborg

    Unit of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  5. Andreas Hellander

    Department of Information Technology, Uppsala University, Uppsala, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  6. Josef Jaros

    Department of Histology and Embryology, Medical Faculty, Masaryk University, Brno, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  7. Jozef Kaiser

    Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  8. Julian Petersen

    Center for Brain Research, Medical University Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  9. Bara Szarowska

    Center for Brain Research, Medical University Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  10. Phillip T Newton

    Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  11. Vyacheslav Dyachuk

    Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  12. Lei Li

    Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  13. Hong Qian

    Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  14. Anne-Sofie Johansson

    Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  15. Yuji Mishina

    Department of Biologic and Materials Sciences, University of Michigan School of dentistry, Ann Arbor, United States
    Competing interests
    The authors declare that no competing interests exist.
  16. Josh Currie

    Center for Regenerative Therapies, Technische Universität Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  17. Elly M Tanaka

    Center for Regenerative Therapies, Technische Universität Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  18. Alek Erickson

    Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, United States
    Competing interests
    The authors declare that no competing interests exist.
  19. Andrew Dudley

    Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, United States
    Competing interests
    The authors declare that no competing interests exist.
  20. Hjalmar Brismar

    Science for Life Laboratory, Royal Institute of Technology, Solna, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0578-4003
  21. Paul Southam

    John Innes Centre, Norwich, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  22. Enrico Coen

    John Innes Centre, Norwich, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8454-8767
  23. Min Chen

    National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, United States
    Competing interests
    The authors declare that no competing interests exist.
  24. Lee S Weinstein

    National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, United States
    Competing interests
    The authors declare that no competing interests exist.
  25. Ales Hampl

    Department of Histology and Embryology, Medical Faculty, Masaryk University, Brno, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  26. Ernest Arenas

    Unit of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  27. Andrei S Chagin

    Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2696-5850
  28. Kaj Fried

    Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
    For correspondence
    kaj.fried@ki.se
    Competing interests
    The authors declare that no competing interests exist.
  29. Igor Adameyko

    Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
    For correspondence
    igor.adameyko@ki.se
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5471-0356

Funding

European Molecular Biology Organization (ALTF 216-2013)

  • Marketa Kaucka

Svenska Sällskapet för Medicinsk Forskning

  • Marketa Kaucka

Svenska Forskningsrådet Formas

  • Andreas Hellander
  • Phillip T Newton
  • Andrei S Chagin
  • Kaj Fried
  • Igor Adameyko

Karolinska Institutet

  • Phillip T Newton
  • Andrei S Chagin
  • Kaj Fried
  • Igor Adameyko

Bertil Hållstens Forskningsstiftelse

  • Igor Adameyko

Åke Wiberg Stiftelse

  • Igor Adameyko

National Institutes of Health

  • Andreas Hellander

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal (mouse) work has been approved and permitted by the Ethical Committee on Animal Experiments (Norra Djurförsöksetiska Nämd, ethical permit N226/15 and N5/14) and conducted according to The Swedish Animal Agency´s Provisions and Guidelines for Animal Experimentation recommendations.

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 3,639
    views
  • 701
    downloads
  • 50
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Marketa Kaucka
  2. Tomas Zikmund
  3. Marketa Tesarova
  4. Daniel Gyllborg
  5. Andreas Hellander
  6. Josef Jaros
  7. Jozef Kaiser
  8. Julian Petersen
  9. Bara Szarowska
  10. Phillip T Newton
  11. Vyacheslav Dyachuk
  12. Lei Li
  13. Hong Qian
  14. Anne-Sofie Johansson
  15. Yuji Mishina
  16. Josh Currie
  17. Elly M Tanaka
  18. Alek Erickson
  19. Andrew Dudley
  20. Hjalmar Brismar
  21. Paul Southam
  22. Enrico Coen
  23. Min Chen
  24. Lee S Weinstein
  25. Ales Hampl
  26. Ernest Arenas
  27. Andrei S Chagin
  28. Kaj Fried
  29. Igor Adameyko
(2017)
Oriented clonal cell dynamics enables accurate growth and shaping of vertebrate cartilage
eLife 6:e25902.
https://doi.org/10.7554/eLife.25902

Share this article

https://doi.org/10.7554/eLife.25902

Further reading

    1. Cancer Biology
    2. Developmental Biology
    Sara Jaber, Eliana Eldawra ... Franck Toledo
    Research Article

    Missense ‘hotspot’ mutations localized in six p53 codons account for 20% of TP53 mutations in human cancers. Hotspot p53 mutants have lost the tumor suppressive functions of the wildtype protein, but whether and how they may gain additional functions promoting tumorigenesis remain controversial. Here, we generated Trp53Y217C, a mouse model of the human hotspot mutant TP53Y220C. DNA damage responses were lost in Trp53Y217C/Y217C (Trp53YC/YC) cells, and Trp53YC/YC fibroblasts exhibited increased chromosome instability compared to Trp53-/- cells. Furthermore, Trp53YC/YC male mice died earlier than Trp53-/- males, with more aggressive thymic lymphomas. This correlated with an increased expression of inflammation-related genes in Trp53YC/YC thymic cells compared to Trp53-/- cells. Surprisingly, we recovered only one Trp53YC/YC female for 22 Trp53YC/YC males at weaning, a skewed distribution explained by a high frequency of Trp53YC/YC female embryos with exencephaly and the death of most Trp53YC/YC female neonates. Strikingly, however, when we treated pregnant females with the anti-inflammatory drug supformin (LCC-12), we observed a fivefold increase in the proportion of viable Trp53YC/YC weaned females in their progeny. Together, these data suggest that the p53Y217C mutation not only abrogates wildtype p53 functions but also promotes inflammation, with oncogenic effects in males and teratogenic effects in females.

    1. Developmental Biology
    Mengjie Li, Aiguo Tian, Jin Jiang
    Research Advance

    Stem cell self-renewal often relies on asymmetric fate determination governed by niche signals and/or cell-intrinsic factors but how these regulatory mechanisms cooperate to promote asymmetric fate decision remains poorly understood. In adult Drosophila midgut, asymmetric Notch (N) signaling inhibits intestinal stem cell (ISC) self-renewal by promoting ISC differentiation into enteroblast (EB). We have previously shown that epithelium-derived Bone Morphogenetic Protein (BMP) promotes ISC self-renewal by antagonizing N pathway activity (Tian and Jiang, 2014). Here, we show that loss of BMP signaling results in ectopic N pathway activity even when the N ligand Delta (Dl) is depleted, and that the N inhibitor Numb acts in parallel with BMP signaling to ensure a robust ISC self-renewal program. Although Numb is asymmetrically segregated in about 80% of dividing ISCs, its activity is largely dispensable for ISC fate determination under normal homeostasis. However, Numb becomes crucial for ISC self-renewal when BMP signaling is compromised. Whereas neither Mad RNA interference nor its hypomorphic mutation led to ISC loss, inactivation of Numb in these backgrounds resulted in stem cell loss due to precocious ISC-to-EB differentiation. Furthermore, we find that numb mutations resulted in stem cell loss during midgut regeneration in response to epithelial damage that causes fluctuation in BMP pathway activity, suggesting that the asymmetrical segregation of Numb into the future ISC may provide a fail-save mechanism for ISC self-renewal by offsetting BMP pathway fluctuation, which is important for ISC maintenance in regenerative guts.